twenty-six children greater than 1 year of age with previously untreated stage iv neuroblastoma were randomized to receive either a five-drug regimen ( prednisone , cyclophosphamide , actinomycin d , vincristine , and daunorubicin ) or a two-drug regimen ( cyclophosphamide and vincristine ) .
C0027819
neuroblastoma
C0010934
actinomycin d